Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Forget the Apple Watch: our favourite cheap Garmin is down to a record-low price ahead of Prime Day

    3. Juli 2025

    Dr. Scott Gottlieb on HHS Secretary RFK Jr.’s newly appointed vaccine advisory panel

    3. Juli 2025

    Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis

    3. Juli 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Field Medical raises another $35M for PFA system
    News

    Field Medical raises another $35M for PFA system

    HealthradarBy Healthradar2. Juli 2025Keine Kommentare3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Field Medical raises another M for PFA system
    Share
    Facebook Twitter LinkedIn Pinterest Email


    This audio is auto-generated. Please let us know if you have feedback.

    Dive Brief:

    • Steven Mickelsen’s Field Medical has raised another $35 million in funding to advance preparations for its pivotal trial studying pulsed field ablation to treat ventricular tachycardia.
    • The Series B financing round was led by BioStar Capital and Cue Growth and saw participation from existing strategic investors.
    • Mickelsen is the electrophysiologist who invented the Farapulse PFA system that is helping change how atrial fibrillation is treated and driving fast growth for Boston Scientific. After Boston Scientific acquired Farapulse, Mickelsen founded Field Medical in 2022 to focus on developing a PFA approach for ventricular tachycardia, an irregular heart rhythm that can lead to sudden death.

    Dive Insight:

    Physicians have embraced PFA to treat AFib, a common arrhythmia that increases stroke risk, since Medtronic and Boston Scientific brought the first systems to market in the U.S. in late 2023 and early 2024. The technology offers a potentially safer way to ablate the cardiac tissue causing the abnormal heart rhythm by reducing the risk of harm to the esophagus and can be a faster procedure than traditional ablation methods.

    Johnson & Johnson also sells a PFA device, while Abbott expects the Food and Drug Administration to approve its Volt system in 2026.

    Based in Cardiff-by-the-Sea, California, Field Medical is aiming to expand treatment options for patients who have ventricular tachycardia by designing a PFA system that targets the condition.

    „Ventricular tachycardia is among the most underpenetrated segments in electrophysiology, yet physicians still lack the tools they need,“ Mickelsen, who is Field Medical’s CEO, said in a statement. „What is exciting is how VT is mirroring the early days of the [AFib] market.”

    Existing technology does not meet the current clinical demand, according to the company. 

    Field Medical’s technology “is doing what few companies dare to do – tackling one of the most difficult and under-addressed challenges in cardiology with real innovation and urgency,“ said Louis Cannon, a physician and the founder and senior managing director of BioStar Capital. „Their physician-led team brings the right insight, and their FieldForce platform brings the right tools. We’re proud to support this next chapter as they move closer to transforming VT care.”

    The company’s latest financing follows a $40 million round in April, bringing total funds raised to date to $75 million. The new funds will support the start of the pivotal Veritas trial, further the development of the FieldForce system and expand the company’s clinical and regulatory capabilities.



    Source link

    35M Field Medical PFA raises system
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleJudge approves 23andMe sale to nonprofit led by Anne Wojcicki
    Next Article Healthcare Leads in GenAI Adoption, But Faces Security Hurdles
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis

    3. Juli 2025
    News

    Healthcare Leads in GenAI Adoption, But Faces Security Hurdles

    2. Juli 2025
    News

    Intuitive Surgical’s da Vinci 5 robot wins CE mark

    2. Juli 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20255 Views

    Whoop wants everyone to give a whoop about the new Whoop 5.0

    1. Juni 20254 Views

    Baby Boomers’ Luck Is Running Out

    14. Juni 20253 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20255 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.